Cargando…

Prevalence of Darunavir Resistance in the United States from 2010 to 2017

The emergence and transmission of antiretroviral drug resistance have been and remain a concern among people living with human immunodeficiency virus (HIV)-1 infection. The protease inhibitor (PI) darunavir has been approved for use in the United States for more than 10 years and has demonstrated a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Kimberley, Stewart, Lisa, Whitcomb, Jeannette M., Yang, Dongmei, Nettles, Richard E., Lathouwers, Erkki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306664/ https://www.ncbi.nlm.nih.gov/pubmed/30148406 http://dx.doi.org/10.1089/aid.2018.0100

Ejemplares similares

2509. Pooled Resistance Analyses of Darunavir (DRV) Once Daily (QD) Regimens and Formulations Across 10 Clinical Studies of Treatment-Naïve (TN) and Treatment-Experienced (TE) Patients with Human Immunodeficiency Virus (HIV)-1 Infection
por: Lathouwers, Erkki, et al.
Publicado: (2019)

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study
por: Huhn, Gregory D., et al.
Publicado: (2019)

Projections of cancer prevalence in the United Kingdom, 2010–2040
por: Maddams, J, et al.
Publicado: (2012)

Changing prevalence of darunavir resistance-associated mutations (DRV RAMs) in clinical samples received for routine resistance testing: 2003-2009
por: De La Rosa, G, et al.
Publicado: (2010)

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
por: Lathouwers, Erkki, et al.
Publicado: (2020)

Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir
por: Opsomer, Magda, et al.
Publicado: (2018)

Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated with Darunavir
por: Opsomer, Magda, et al.
Publicado: (2018)

Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States
por: Getman, Damon, et al.
Publicado: (2016)

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States
por: Ross, Lisa L., et al.
Publicado: (2018)

Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017
por: Fwelo, Pierre, et al.
Publicado: (2022)

Prevalence and Trends in Cigarette Smoking Among Adults with Epilepsy — United States, 2010–2017
por: Sapkota, Sanjeeb, et al.
Publicado: (2020)

Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability
por: Crocetti, E, et al.
Publicado: (2013)

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
por: Eron, Joseph J., et al.
Publicado: (2018)

Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010–2019)
por: Carvalhaes, Cecilia G., et al.
Publicado: (2022)

Combating HIV resistance – focus on darunavir
por: Tremblay, Cécile L
Publicado: (2008)

Prevalence and incidence rates of autism in the UK: time trend from 2004–2010 in children aged 8 years
por: Taylor, Brent, et al.
Publicado: (2013)

Cancer prevalence in the United Kingdom: estimates for 2008
por: Maddams, J, et al.
Publicado: (2009)

Hepatitis C Screening and Antibody Prevalence Among Newly Arrived Refugees to the United States, 2010–2017
por: Urban, Kailey, et al.
Publicado: (2023)

Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992–2017
por: Yu, Dahai, et al.
Publicado: (2023)

Population ageing and injurious falls among one million elderly people who used emergency medical services from 2010 to 2017 in Beijing, China: a longitudinal observational study
por: Zhao, Siyu, et al.
Publicado: (2019)

Prevalence, awareness, treatment, and control of hypertension in Bangladesh: Findings from National Demographic and Health Survey, 2017–2018
por: Khan, Md. Nuruzzaman, et al.
Publicado: (2021)

Descriptive epidemiology of ependymal tumours in the United States
por: Villano, J L, et al.
Publicado: (2013)

Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy
por: Marcelin, AG, et al.
Publicado: (2010)

Diabetes mellitus among adults with tuberculosis in the USA, 2010–2017
por: Armstrong, Lori R, et al.
Publicado: (2020)

The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
por: Klein, Eili Y, et al.
Publicado: (2020)

Geospatial Variation in Rotavirus Vaccination in Infants, United States, 2010–2017
por: Rogers, Mary A.M., et al.
Publicado: (2019)

Healthy food retail availability and cardiovascular mortality in the United States: a cohort study
por: Lovasi, Gina S, et al.
Publicado: (2021)

Cross-sectional study on the characteristics of unrecorded alcohol consumption in nine newly independent states between 2013 and 2017
por: Probst, Charlotte, et al.
Publicado: (2021)

Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010
por: Aitken, Grant R, et al.
Publicado: (2014)

Structures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open Flaps
por: Zhang, Ying, et al.
Publicado: (2014)

Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study
por: Zhang, Xin, et al.
Publicado: (2021)

Newly incident cannabis use in the United States, 2002–2011: a regional and state level benchmark
por: Leinweber, Jacob P., et al.
Publicado: (2017)

Trends in smoking during pregnancy by socioeconomic characteristics in the United States, 2010–2017
por: Azagba, Sunday, et al.
Publicado: (2020)

Travel-Associated and Locally Acquired Dengue Cases — United States, 2010–2017
por: Rivera, Aidsa, et al.
Publicado: (2020)

2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
por: Klein, Eili, et al.
Publicado: (2019)

Shiga Toxin-Producing Escherichia coli Outbreaks in the United States, 2010–2017
por: Tack, Danielle M., et al.
Publicado: (2021)

Cancer in Lahore, Pakistan, 2010–2019: an incidence study
por: Badar, Farhana, et al.
Publicado: (2022)

Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
por: Ge, Xiaojun, et al.
Publicado: (2020)

Secular trends of hypertension prevalence based on 2017 ACC/AHA and 2018 Chinese hypertension guidelines: Results from CHNS data (1991‐2015)
por: Zheng, Liqiang, et al.
Publicado: (2020)

Risk of lymphoma subtypes after solid organ transplantation in the United States
por: Clarke, C A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tnnurnshogmkl4t3g0lf1n5nr1